首页> 外文期刊>Pediatric Pulmonology >Polysomnographic characteristics in patients with mucopolysaccharidoses.
【24h】

Polysomnographic characteristics in patients with mucopolysaccharidoses.

机译:粘多糖病患者的多导睡眠图特征。

获取原文
获取原文并翻译 | 示例
       

摘要

To evaluate the prevalence of obstructive sleep apnea (OSA) and to clarify sleep characteristics in patients with mucopolysaccharidoses (MPS), we performed overnight polysomnographic studies in 24 patients (22 males and 2 females; 3 with MPS I, 15 with MPS II, 1 with MPS III, 1 with MPS IV, and 4 with MPS VI; mean age, 10.8 +/- 6.0 years; age range, 2.0-23.7 years; 2 patients >/=18 years of age). The nadir arterial oxygen saturation (SaO(2) ) was 74.5 +/- 12.3%, and the average percentage of sleep time with an SaO(2) of <95% was 39.4%. The percentages of total sleep time spent in sleep stages N1, N2, N3, and R were 18.6 +/- 10.8%, 50.3 +/- 7.6%, 14.8 +/- 8.1%, and 15.3 +/- 4.6%, respectively. The respiratory disturbance index (RDI) was 21.8 +/- 20.4/hr, and obstructive apnea-hypopnea index (OAHI) and central apnea index were 21.4 +/- 19.9/hr and 0.4 +/- 0.6/hr, respectively. The desaturation index was 17.6 +/- 17.8/hr. All patients had some degree of OSA. For 22 children, the disorder was mild (OAHI 1.5-5) in 2, moderate (OAHI 5-10) in 7, and severe (OAHI > 10) in 13. Two patients with MPS II who received enzyme replacement therapy had reductions in RDI after treatment (38.9-10.8 and 3.5-2.0, respectively). The prevalence of moderate to severe OSA was 88% (21/24) in patients with MPS. The overnight polysomnography will help to determine the abnormalities of breathing during sleep more precisely and urge the clinicians to take necessary action for patients with severe manifestations.
机译:为了评估阻塞性睡眠呼吸暂停(OSA)的患病率并阐明粘多糖贮积症(MPS)患者的睡眠特征,我们对24例患者(22例男性和2例女性; 3例MPS I,15例MPS II,1例)进行了多导睡眠监测研究MPS III; MPS IV 1例; MPS VI 4例;平均年龄:10.8 +/- 6.0岁;年龄范围:2.0-23.7岁; 2岁以上(≥18岁)。天底动脉血氧饱和度(SaO(2))为74.5 +/- 12.3%,SaO(2)<95%的平均睡眠时间百分比为39.4%。在睡眠阶段N1,N2,N3和R中花费的总睡眠时间百分比分别为18.6 +/- 10.8%,50.3 +/- 7.6%,14.8 +/- 8.1%和15.3 +/- 4.6%。呼吸障碍指数(RDI)为21.8 +/- 20.4 / hr,阻塞性呼吸暂停低通气指数(OAHI)和中枢性呼吸暂停指数分别为21.4 +/- 19.9 / hr和0.4 +/- 0.6 / hr。脱饱和指数为17.6 +/- 17.8 / hr。所有患者均有一定程度的OSA。对于22名儿童,该病轻度(OAHI 1.5-5)在2中,中度(OAHI 5-10)在7中,重度(OAHI> 10)在13中。两名接受酶替代疗法的MPS II患者的病情有所降低。治疗后的RDI(分别为38.9-10.8和3.5-2.0)。 MPS患者中重度OSA的患病率为88%(21/24)。夜间多导睡眠监测有助于更准确地确定睡眠中的呼吸异常,并敦促临床医生对表现严重的患者采取必要的措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号